Get started
Author

Stephanie L. Pritzl

Observed names: S. Pritzl, Stephanie L Pritzl, Stephanie Pritzl
ORCID: 0000-0001-9718-9927
Observed ORCID: 0000-0001-9718-9927
OpenAlex ID: A5019119343
Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study
2022 · Stephanie L. Pritzl, Mark Gurney, et al. · Leukemia Research · 13
Spectrum of therapy-related clonal cytopenias and neoplasms after exposure to Lutetium-177-Dotatate
2023 · Stephanie L. Pritzl, Yael Kusne, et al. · Leukemia Research · 11
The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab
2023 · Katherine E.R. Smith, Stephanie L. Pritzl, et al. · JTO Clinical and Research Reports · 9
PDF
Trajectory of Global Mental Health and Global Physical Health in Breast Cancer Survivorship
2025 · Stephanie L. Pritzl, Robert A. Vierkant, et al. · Journal of the National Comprehensive Cancer Network · 7
PDF
Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia
2021 · Stephanie L. Pritzl, Daniel R. Matson, et al. · Case Reports in Hematology · 7
PDF
Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell state
2022 · Amani A. Gillette, Rebecca A. DeStefanis, et al. · Journal of Biomedical Optics · 5
PDF
Current Trends in HPV Vaccine Uptake: Wisconsin and United States, 2016-2019.
2021 · Alexandria Cull Weatherer, Stephanie L Pritzl, et al. · PubMed · 5
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA -Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al. · Molecular Cancer Therapeutics · 4
HIV-1 RNA genomes initiate host protein packaging in the cytosol independently of Gag capsid proteins
2019 · Jordan T. Becker, Edward L. Evans, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Enrichment of somatic mosaic states involving DNA damage response and repair genes in patients treated with 177Lutetium.
2024 · Yael Kusne, Osama M Mosalem, et al. · Journal of Clinical Oncology · 2
PDF
Data from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al. · 1
Standardizing Research Training: a Pilot Curriculum Within a Hematology/Oncology Fellowship Program
2022 · Stephanie L. Pritzl, Laura M. Lang, et al. · Journal of Cancer Education · 1
Blood Board: A virtual community of practice for classical hematology education and care improvement
2026 · Richard C. Godby, Jennifer Gile, et al. · Blood Cells Molecules and Diseases
Supplementary Figure 3 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al.
PDF
Supplementary Figure 2 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al.
PDF
Supplementary Figure 1 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al.
PDF
Supplementary Data File from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al.
Supplementary Figure 4 from BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer
2025 · Rebecca A. DeStefanis, Alexa E. Schmitz, et al.
PDF
Blood board: A virtual forum for classical hematology education and care improvement
2025 · Richard Godby, Xavier Andrade-Gonzalez, et al. · Blood
Abstract PO1-09-03: Clinical Impact of Multigene Panel Testing in Patients with a Personal or Family History of Breast or Ovarian Cancer Previously Negative for BRCA1/2 Genes
2024 · Devon Miller, Stephanie Pritzl, et al. · Cancer Research
139P The timing, dynamics, and co-occurrence of immune-related adverse events with a PD-L1 inhibitor in non-small cell lung cancer
2022 · K.E. Smith, S. Pritzl, et al. · Immuno-Oncology Technology
PDF
U2AF1 Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with BCOR Mutations
2022 · Stephanie L. Pritzl, Talha Badar, et al. · Blood
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study
2022 · Jana Wieland, Daniel Satele, et al. · Journal of Patient Experience
PDF
Perceptions of research training in a hematology/oncology fellowship program.
2020 · Stephanie L Pritzl, Laura M Lang, et al. · Journal of Clinical Oncology
Works count: 24
Citation count: 69
H-index: 5
I10-index: 2
Year
Topic
Type